0.28 (-%)
As of Oct 30, 2024
Source:
Aptevo Therapeutics Inc. is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapy candidates for the treatment of different forms of cancer. We have developed two versatile and enabling platform technologies for rational design of precision immune modulatory drugs and have two clinical candidates and three preclinical candidates currently in development.
Country | United States |
Headquarters | seattle, washington |
Phone Number | (206) 838-0500 |
Industry | manufacturing |
CEO | Marvin L. White |
Website | www.aptevotherapeutics.com |